Lista de obras -

A large case-control study on vaccination as risk factor for multiple sclerosis

artículo científico publicado en 2019

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica

Aggressive multiple sclerosis (1): Towards a definition of the phenotype

artículo científico publicado en 2020

Aggressive multiple sclerosis (2): Treatment

artículo científico publicado en 2020

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

artículo científico publicado en 2013

Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS

scientific article published on 24 December 2020

Class II HLA interactions modulate genetic risk for multiple sclerosis

artículo científico publicado en 2015

Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy

scientific article published on 23 April 2020

Consensus guidelines for lumbar puncture in patients with neurological diseases

artículo científico publicado en 2017

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

scientific article published on 18 January 2020

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

artículo científico publicado en 2018

Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms

artículo científico publicado en 2020

Genetic determinants of the humoral immune response in MS

artículo científico publicado en 2020

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

artículo científico publicado en 2011

Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis

artículo científico publicado en 2020

Is APOE ε4 associated with cognitive performance in early MS?

scientific article published on 01 May 2020

Low frequency and rare coding variation contributes to multiple sclerosis risk

Neurofilament ELISA validation

artículo científico publicado en 2009

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

artículo científico publicado en 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

artículo científico publicado en 2016

Power estimation for non-standardized multisite studies

artículo científico publicado en 2016

Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS

scientific article published on 09 January 2020

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

artículo científico

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

artículo científico publicado en 2013

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

artículo científico publicado en 2021

T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis

artículo científico publicado en 2020

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

scholarly article published 13 July 2017

The spectrum of aseptic central nervous system infections in southern Germany - demographic, clinical and laboratory findings

artículo científico publicado en 2017

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

scientific article published on 04 November 2020

Vaccination in B-cell depleted MS patients

artículo científico publicado en 2020

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT

scientific article published on 16 April 2020

Lista de obras de

A large case-control study on vaccination as risk factor for multiple sclerosis

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Aggressive multiple sclerosis (1): Towards a definition of the phenotype

Aggressive multiple sclerosis (2): Treatment

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS

Class II HLA interactions modulate genetic risk for multiple sclerosis

Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy

Consensus guidelines for lumbar puncture in patients with neurological diseases

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms

Genetic determinants of the humoral immune response in MS

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis

Is APOE ε4 associated with cognitive performance in early MS?

Low frequency and rare coding variation contributes to multiple sclerosis risk

Neurofilament ELISA validation

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Power estimation for non-standardized multisite studies

Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

The spectrum of aseptic central nervous system infections in southern Germany - demographic, clinical and laboratory findings

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Vaccination in B-cell depleted MS patients

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT